| Financial Year |
March 31 2023 |
| Monetary Funds |
921,224,389.04 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
45,066,627.20 |
| Accounts Receivable |
144,496,923.18 |
| Advances to Suppliers |
26,289,611.65 |
| Other Receivables |
16,574,663.82 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
221,662,003.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,321,966.92 |
| Total Current Assets |
1,435,686,947.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
47,025,014.30 |
| Investment Properties |
56,378,316.61 |
| Fixed Assetes |
520,162,539.33 |
| Under-construction Projects |
218,377,363.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
221,311,712.84 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,599,353.23 |
| Deferred Income Tax Assets |
12,806,902.37 |
| Other Non-Current Assets |
16,830,377.81 |
| Sub-Total of Non-Current Assets |
1,359,275,774.65 |
| Total Assets |
2,794,962,722.51 |
| Short-Term Loans |
5,005,576.39 |
| Trading Financial liabilities |
-- |
| Notes Payable |
77,836,470.14 |
| Accounts Payable |
161,388,668.36 |
| Accounts Received In Advance |
3,333,584.77 |
| Employee Compensation Payable |
17,453,413.45 |
| Taxes Payable |
10,453,337.35 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
29,614,419.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
323,872,386.63 |
| Other Current Liabilities |
13,270,156.75 |
| Sub-Total of Current Liabilities |
744,306,141.88 |
| Long-term Loans |
84,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,483,691.71 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
183,854,044.83 |
| Total Liabilities |
928,160,186.71 |
| Paid-In Capital(Or Share Stock) |
472,621,118.00 |
| Capital Surplus |
351,774,522.35 |
| Surplus Reserve |
76,885,285.78 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
859,138,444.93 |
| Minority Stockholder's Interest |
122,244,969.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,744,557,566.41 |
| Owner's Equity（Stockholder's Equity） |
1,866,802,535.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,794,962,722.51 |
